日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Extended Anticoagulation Therapy With Rivaroxaban for Cancer-Associated Low-Risk Pulmonary Embolism According to Different Performance Status Scores: Insights From the ONCO PE Randomized Trial

根据不同的体能状态评分,对癌症相关低风险肺栓塞患者进行利伐沙班延长抗凝治疗:来自 ONCO PE 随机试验的启示

Xiong, Wei; Yamashita, Yugo; Morimoto, Takeshi; Muraoka, Nao; Shioyama, Wataru; Nakagawa, Yoshihisa; Chatani, Ryuki; Yamamoto, Hiromi; Shibata, Tatsuhiro; Morikawa, Nagisa; Fukumoto, Yoshihiro; Nishimoto, Yuji; Ono, Koh; Kimura, Takeshi

Prevalence and clinical significance of guideline-directed medical therapy in acute heart failure with reduced or mildly reduced ejection fraction

指南指导的药物治疗在射血分数降低或轻度降低的急性心力衰竭中的普及率和临床意义

Miyoshi, Yutaro; Kato, Takao; Morimoto, Takeshi; Ozasa, Neiko; Yaku, Hidenori; Inuzuka, Yasutaka; Tamaki, Yodo; Yamamoto, Erika; Yoshikawa, Yusuke; Kitai, Takeshi; Iguchi, Moritake; Nagao, Kazuya; Kawase, Yuichi; Morinaga, Takashi; Furukawa, Yutaka; Ando, Kenji; Sato, Yukihito; Kuwahara, Koichiro; Ono, Koh; Kimura, Takeshi

Restrictive filling pattern of transmitral inflow in acute decompensated heart failure with preserved ejection fraction: insights from the KCHF registry

射血分数保留型急性失代偿性心力衰竭患者二尖瓣血流灌注受限模式:来自KCHF注册研究的启示

Miyoshi, Yutaro; Kato, Takao; Morimoto, Takeshi; Ozasa, Neiko; Yaku, Hidenori; Inuzuka, Yasutaka; Tamaki, Yodo; Yamamoto, Erika; Yoshikawa, Yusuke; Kitai, Takeshi; Iguchi, Moritake; Nagao, Kazuya; Kawase, Yuichi; Morinaga, Takashi; Furukawa, Yutaka; Ando, Kenji; Sato, Yukihito; Kuwahara, Koichiro; Ono, Koh; Kimura, Takeshi

Critical Role of microRNA-33a/b in Cardiovascular and Metabolic Disease: Molecular Mechanisms and Therapeutic Perspectives

microRNA-33a/b在心血管和代谢疾病中的关键作用:分子机制和治疗前景

Horie, Takahiro; Baba, Osamu; Nishino, Tomohiro; Yamashita, Yugo; Tsujisaka, Yuta; Ono, Koh

Effect of Proton Pump Inhibitors in Patients Undergoing Percutaneous Coronary Intervention With Aspirin-Free Strategy

质子泵抑制剂对接受无阿司匹林策略经皮冠状动脉介入治疗患者的影响

Nishikura, Tenjin; Yamamoto, Ko; Wakabayashi, Kohei; Natsuaki, Masahiro; Watanabe, Hirotoshi; Morimoto, Takeshi; Obayashi, Yuki; Nishikawa, Ryusuke; Kimura, Tomoya; Ando, Kenji; Suwa, Satoru; Isawa, Tsuyoshi; Takenaka, Hiroyuki; Ishikawa, Tetsuya; Onishi, Yuko; Hibi, Kiyoshi; Kawai, Kazuya; Murakami, Tsutomu; Takasaki, Akihiro; Higashitani, Nobuya; Nakano, Masataka; Ono, Koh; Kimura, Takeshi

Predictors of Bleeding Complications After Extracorporeal Cardiopulmonary Resuscitation: Insights From the SAVE-J II Study

体外心肺复苏后出血并发症的预测因素:来自 SAVE-J II 研究的启示

Sano, Madoka; Toyota, Toshiaki; Matsuoka, Yoshinori; Kohjitani, Hirohiko; Watanabe, Yusuke; Azumi, Yuta; Hayashi, Hideyuki; Murai, Ryosuke; Ooka, Junichi; Sasaki, Yasuhiro; Taniguchi, Tomohiko; Kim, Kitae; Kobori, Atsushi; Ehara, Natsuhiko; Kinoshita, Makoto; Inoue, Akihiko; Hifumi, Toru; Sakamoto, Tetsuya; Kuroda, Yasuhiro; Yamamoto, Yosuke; Ariyoshi, Koichi; Okuno, Yasushi; Ono, Koh; Furukawa, Yutaka

Cardiac Damage Stages and Clinical Outcomes in Patients With Severe Aortic Stenosis

重度主动脉瓣狭窄患者的心脏损伤分期和临床结局

Takeji, Yasuaki; Taniguchi, Tomohiko; Morimoto, Takeshi; Shirai, Shinichi; Kitai, Takeshi; Tabata, Hiroyuki; Ohno, Nobuhisa; Murai, Ryosuke; Osakada, Kohei; Murata, Koichiro; Nakai, Masanao; Tsuneyoshi, Hiroshi; Tada, Tomohisa; Amano, Masashi; Watanabe, Shin; Shiomi, Hiroki; Watanabe, Hirotoshi; Yoshikawa, Yusuke; Nishikawa, Ryusuke; Obayashi, Yuki; Yamamoto, Ko; Toyofuku, Mamoru; Tatsushima, Shojiro; Kanamori, Norio; Miyake, Makoto; Nakayama, Hiroyuki; Nagao, Kazuya; Izuhara, Masayasu; Nakatsuma, Kenji; Inoko, Moriaki; Fujita, Takanari; Kimura, Masahiro; Ishii, Mitsuru; Usami, Shunsuke; Nakazeki, Fumiko; Togi, Kiyonori; Inuzuka, Yasutaka; Ando, Kenji; Komiya, Tatsuhiko; Ono, Koh; Minatoya, Kenji; Kimura, Takeshi

Association of Geographical Distance and Residential Population Density With Clinical Outcomes in Acute Decompensated Heart Failure: Insights From the Kyoto Congestive Heart Failure (KCHF) Registry

地理距离和居住人口密度与急性失代偿性心力衰竭临床结局的关系:来自京都充血性心力衰竭(KCHF)注册研究的启示

Yamamoto, Erika; Kato, Takao; Morimoto, Takeshi; Yaku, Hidenori; Inuzuka, Yasutaka; Tamaki, Yodo; Ozasa, Neiko; Yoshikawa, Yusuke; Kitai, Takeshi; Taniguchi, Ryoji; Iguchi, Moritake; Nagao, Kazuya; Nishikawa, Ryusuke; Kadota, Kazushige; Furukawa, Yutaka; Ando, Kenji; Sato, Yukihito; Kuwahara, Koichiro; Kimura, Takeshi; Ono, Koh

Abrogation of aberrant glycolytic interactions eliminates senescent cells and alleviates aging-related dysfunctions.

消除异常的糖酵解相互作用可以消除衰老细胞,缓解与衰老相关的机能障碍。

Mikawa Takumi, Kameda Masahiro, Ikari Sumiko, Shibata Eri, Liu Shuyu, Miyagawa Sawa, Ono Koh, Ito Tomiko, Yoshizawa Akihiko, Sugimoto Masataka, Shibuya Shuichi, Shimizu Takahiko, Almunia Julio, Ogiso Noboru, Revêchon Gwladys, Palazzo Alberta, Bernard David, Kanda Hiroaki, Soga Tomoyoshi, Takubo Keiyo, Morioka Shin, Sasaki Junko, Sasaki Takehiko, Itamoto Akihiro, Fujii Takayuki, Seno Hiroshi, Inagaki Nobuya, Kondoh Hiroshi

Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)

利伐沙班治疗癌症合并急性低风险肺栓塞患者 18 个月与 6 个月的疗效比较:一项开放标签、多中心、随机临床试验(ONCO PE 试验)

Yamashita, Yugo; Morimoto, Takeshi; Muraoka, Nao; Shioyama, Wataru; Chatani, Ryuki; Shibata, Tatsuhiro; Nishimoto, Yuji; Ogihara, Yoshito; Doi, Kosuke; Oi, Maki; Shiga, Taro; Sueta, Daisuke; Kim, Kitae; Tanabe, Yasuhiro; Koitabashi, Norimichi; Takada, Takuma; Ikeda, Satoshi; Nakagawa, Hitoshi; Tsukahara, Kengo; Shoji, Masaaki; Sakamoto, Jiro; Hisatake, Shinji; Ogino, Yutaka; Fujita, Masashi; Nakanishi, Naohiko; Dohke, Tomohiro; Hiramori, Seiichi; Nawada, Ryuzo; Kaneda, Kazuhisa; Ono, Koh; Kimura, Takeshi